相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions
Annika J. Bock et al.
HUMAN PATHOLOGY (2012)
Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival
Kjersti Brenne et al.
HUMAN PATHOLOGY (2012)
The diagnostic and molecular characteristics of malignant mesothelioma and ovarian/peritoneal serous carcinoma
B. Davidson
CYTOPATHOLOGY (2011)
PINCH-2 expression in cancers involving serosal effusions using quantitative PCR
Y. Yuan et al.
CYTOPATHOLOGY (2011)
Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma
Cyril Cuffel et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Retinoids Regulate Stem Cell Differentiation
Lorraine J. Gudas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Derivation of molecular signatures for breast cancer recurrence prediction using a two-way validation approach
Yijun Sun et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Leucine-rich repeat protein PRAME: expression, potential functions and clinical implications for leukaemia
Frances Wadelin et al.
MOLECULAR CANCER (2010)
Tenascin-X is a Novel Diagnostic Marker of Malignant Mesothelioma
Yuan Yuan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomast
Karolina Partheen et al.
BMC CANCER (2009)
Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions
Yuan Yuan et al.
HUMAN PATHOLOGY (2009)
PRAME expression and clinical outcome of breast cancer
M. T. Epping et al.
BRITISH JOURNAL OF CANCER (2008)
Leukemia-Associated Antigens Are Critical for the Proliferation of Acute Myeloid Leukemia Cells
Jochen Greiner et al.
CLINICAL CANCER RESEARCH (2008)
Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas
Karolina Partheen et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prevalence and prognostic and predictive relevance of PRAME in breast cancer
Padraig Doolan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Systematic search for the best gene expression markers for melanoma micrometastasis detection
J. Soikkeli et al.
JOURNAL OF PATHOLOGY (2007)
Corepressors of agonist-bound nuclear receptors
Igor Gurevich et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Hypomethylation of PRAMS is responsible for its aberrant overexpression in human malignancies
Tino Schenk et al.
GENES CHROMOSOMES & CANCER (2007)
Anatomic site-related expression of cancer-associated molecules in ovarian carcinoma
Ben Davidson
CURRENT CANCER DRUG TARGETS (2007)
A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer
Mirjam. T. Epping et al.
CANCER RESEARCH (2006)
Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors
Karolina Partheen et al.
EUROPEAN JOURNAL OF CANCER (2006)
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma
Ben Davidson et al.
CLINICAL CANCER RESEARCH (2006)
Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: Immunotherapeutic implications
Fabio Morandi et al.
NEOPLASIA (2006)
Expression of cancer testis antigens in head and neck squamous cell carcinomas
David L. A. Figueiredo et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2006)
The human tumor antigen repressor of retinoic acid PRAME is a dominant receptor signaling
MT Epping et al.
CELL (2005)
Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
SL Smith et al.
BRITISH JOURNAL OF CANCER (2005)
Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo
N Tajeddine et al.
CANCER RESEARCH (2005)
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine
L Sigalotti et al.
CANCER RESEARCH (2004)
The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome
A Oberthuer et al.
CLINICAL CANCER RESEARCH (2004)
Simultaneous expression of T-cell activating antigens in renal cell carcinoma:: Implications for specific immunotherapy
M Ringhoffer et al.
JOURNAL OF UROLOGY (2004)
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program
E Beillard et al.
LEUKEMIA (2003)
Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes
K Boon et al.
ONCOGENE (2003)
Expression of cancer/testis tumor associated antigens in cervical squamous cell carcinoma
B Sarcevic et al.
ONCOLOGY (2003)
Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition
CM Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
分享论文
